Julie C. Stout
Affiliations: | Monash University, Caulfield East, Victoria, Australia |
Area:
striatal-frontal systems, Huntington's DiseaseGoogle:
"Julie Stout"Mean distance: 14.6 (cluster 15) | S | N | B | C | P |
Parents
Sign in to add mentor| Janice K. Kiecolt-Glaser | research assistant | 1983-1985 | Ohio State |
| Jay M. Weiss | grad student | 1985-1991 | Duke |
| Nelson Butters | post-doc | Monash University | |
| Terry L. Jernigan | post-doc | 1992-1995 | University of California, San Diego School of Medicine |
Children
Sign in to add trainee| Shannon A. Johnson | grad student | Monash University | |
| Scott A. Wylie | grad student | 2002 | Indiana University Bloomington |
| Meghan C. Campbell | grad student | 2000-2004 | Indiana University Bloomington |
| Andrea C. Solomon | grad student | 2008 | Indiana University Bloomington |
| Christopher Shirbin | grad student | 2008-2012 | Monash University |
| Anthony J. Bishara | post-doc | Indiana University Bloomington | |
| Safa Zaki | post-doc | Indiana University Bloomington | |
| Eldad Yehiam | post-doc | 2003-2005 | Indiana University Bloomington |
Collaborators
Sign in to add collaborator| Sarah Tabrizi | collaborator | Monash University | |
| Jerome R. Busemeyer | collaborator | 2000- | Indiana University Bloomington |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Reilmann R, Anderson KE, Feigin A, et al. (2024) Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study. The Lancet. Neurology |
| Atkins KJ, Andrews SC, Stout JC, et al. (2024) The effect of Huntington's disease on cognitive and physical motivation. Brain : a Journal of Neurology |
| Chan JCS, Stout JC, Shirbin CA, et al. (2021) Listener Detection of Objectively Validated Acoustic Features of Speech in Huntington's Disease. Journal of Huntington's Disease |
| Abreu D, Ware J, Georgiou-Karistianis N, et al. (2021) Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects. Frontiers in Neurology. 12: 595679 |
| Wasser CI, Mercieca EC, Kong G, et al. (2020) Gut dysbiosis in Huntington's disease: associations among gut microbiota, cognitive performance and clinical outcomes. Brain Communications. 2: fcaa110 |
| McLaren B, Andrews SC, Glikmann-Johnston Y, et al. (2020) Feasibility and initial validation of 'HD-Mobile', a smartphone application for remote self-administration of performance-based cognitive measures in Huntington's disease. Journal of Neurology |
| Andrews SC, Langbehn DR, Craufurd D, et al. (2020) Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease. Psychological Medicine. 1-7 |
| Carlozzi NE, Schilling SG, Boileau NR, et al. (2019) How different aspects of motor dysfunction influence day-to-day function in huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society |
| Ross CA, Reilmann R, Cardoso F, et al. (2019) Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories. Movement Disorders Clinical Practice. 6: 541-546 |
| Carmichael AM, Irish M, Glikmann-Johnston Y, et al. (2019) Discrete changes in the frequency and functions of autobiographical reminiscence in Huntington's disease. Memory (Hove, England). 1-7 |